Bioequivalencia e intercambio terapéutico de especialidades farmacéuticas: aplicación a ciclosporina en trasplante renal
J. J. PÉREZ RUIXO , B. PORTA , N. V. JIMÉNEZ TORRES
Leído
9806
Vecesse ha leído el artículo
2604
Total PDF
7202
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 65 | 17 | 82 |
| 2025 5 | 118 | 62 | 180 |
| 2025 4 | 99 | 26 | 125 |
| 2025 3 | 108 | 52 | 160 |
| 2025 2 | 110 | 33 | 143 |
| 2025 1 | 102 | 51 | 153 |
| 2024 12 | 59 | 27 | 86 |
| 2024 11 | 92 | 68 | 160 |
| 2024 10 | 71 | 46 | 117 |
| 2024 9 | 66 | 44 | 110 |
| 2024 8 | 61 | 81 | 142 |
| 2024 7 | 50 | 30 | 80 |
| 2024 6 | 53 | 25 | 78 |
| 2024 5 | 94 | 36 | 130 |
| 2024 4 | 66 | 26 | 92 |
| 2024 3 | 39 | 19 | 58 |
| 2024 2 | 52 | 35 | 87 |
| 2024 1 | 43 | 25 | 68 |
| 2023 12 | 54 | 40 | 94 |
| 2023 11 | 50 | 33 | 83 |
| 2023 10 | 68 | 30 | 98 |
| 2023 9 | 101 | 21 | 122 |
| 2023 8 | 46 | 18 | 64 |
| 2023 7 | 54 | 31 | 85 |
| 2023 6 | 72 | 34 | 106 |
| 2023 5 | 70 | 30 | 100 |
| 2023 4 | 33 | 23 | 56 |
| 2023 3 | 51 | 40 | 91 |
| 2023 2 | 32 | 21 | 53 |
| 2022 1 | 53 | 21 | 74 |
| 2022 12 | 44 | 32 | 76 |
| 2022 11 | 44 | 24 | 68 |
| 2022 10 | 68 | 45 | 113 |
| 2022 9 | 43 | 28 | 71 |
| 2022 8 | 49 | 37 | 86 |
| 2022 7 | 51 | 50 | 101 |
| 2022 6 | 36 | 39 | 75 |
| 2022 5 | 52 | 23 | 75 |
| 2022 4 | 53 | 42 | 95 |
| 2022 3 | 43 | 38 | 81 |
| 2022 2 | 50 | 39 | 89 |
| 2021 1 | 76 | 22 | 98 |
| 2021 12 | 45 | 35 | 80 |
| 2021 11 | 64 | 28 | 92 |
| 2021 10 | 72 | 48 | 120 |
| 2021 9 | 55 | 35 | 90 |
| 2021 8 | 50 | 31 | 81 |
| 2021 7 | 41 | 31 | 72 |
| 2021 6 | 62 | 34 | 96 |
| 2021 5 | 73 | 31 | 104 |
| 2021 4 | 173 | 90 | 263 |
| 2021 3 | 86 | 23 | 109 |
| 2021 2 | 65 | 34 | 99 |
| 2020 1 | 59 | 22 | 81 |
| 2020 12 | 42 | 13 | 55 |
| 2020 11 | 39 | 9 | 48 |
| 2020 10 | 36 | 11 | 47 |
| 2020 9 | 41 | 12 | 53 |
| 2020 8 | 47 | 8 | 55 |
| 2020 7 | 60 | 35 | 95 |
| 2020 6 | 41 | 20 | 61 |
| 2020 5 | 61 | 15 | 76 |
| 2020 4 | 85 | 32 | 117 |
| 2020 3 | 92 | 10 | 102 |
| 2020 2 | 69 | 23 | 92 |
| 2020 1 | 76 | 29 | 105 |
| 2019 12 | 56 | 14 | 70 |
| 2019 11 | 46 | 15 | 61 |
| 2019 10 | 399 | 26 | 425 |
| 2019 9 | 68 | 24 | 92 |
| 2019 8 | 23 | 27 | 50 |
| 2019 7 | 32 | 15 | 47 |
| 2019 6 | 30 | 4 | 34 |
| 2019 5 | 19 | 7 | 26 |
| 2019 4 | 53 | 35 | 88 |
| 2019 3 | 21 | 15 | 36 |
| 2019 2 | 22 | 10 | 32 |
| 2019 1 | 14 | 6 | 20 |
| 2018 12 | 48 | 17 | 65 |
| 2018 11 | 46 | 17 | 63 |
| 2018 10 | 56 | 19 | 75 |
| 2018 9 | 43 | 13 | 56 |
| 2018 8 | 30 | 9 | 39 |
| 2018 7 | 14 | 12 | 26 |
| 2018 6 | 38 | 11 | 49 |
| 2018 5 | 33 | 5 | 38 |
| 2018 4 | 45 | 12 | 57 |
| 2018 3 | 30 | 5 | 35 |
| 2018 2 | 15 | 2 | 17 |
| 2018 1 | 17 | 9 | 26 |
| 2017 12 | 23 | 6 | 29 |
| 2017 11 | 28 | 6 | 34 |
| 2017 10 | 21 | 9 | 30 |
| 2017 9 | 30 | 5 | 35 |
| 2017 8 | 30 | 5 | 35 |
| 2017 7 | 19 | 5 | 24 |
| 2017 6 | 24 | 4 | 28 |
| 2017 5 | 23 | 20 | 43 |
| 2017 4 | 24 | 6 | 30 |
| 2017 3 | 22 | 15 | 37 |
| 2017 2 | 22 | 7 | 29 |
| 2016 1 | 15 | 13 | 28 |
| 2016 12 | 22 | 10 | 32 |
| 2016 11 | 46 | 6 | 52 |
| 2016 10 | 55 | 5 | 60 |
| 2016 9 | 86 | 11 | 97 |
| 2016 8 | 129 | 11 | 140 |
| 2016 7 | 102 | 8 | 110 |
| 2016 6 | 95 | 0 | 95 |
| 2016 5 | 103 | 0 | 103 |
| 2016 4 | 69 | 0 | 69 |
| 2016 3 | 69 | 0 | 69 |
| 2016 2 | 90 | 0 | 90 |
| 2015 1 | 80 | 0 | 80 |
| 2015 12 | 92 | 0 | 92 |
| 2015 11 | 82 | 0 | 82 |
| 2015 10 | 77 | 0 | 77 |
| 2015 9 | 77 | 0 | 77 |
| 2015 8 | 79 | 0 | 79 |
| 2015 7 | 92 | 0 | 92 |
| 2015 6 | 30 | 0 | 30 |
| 2015 5 | 64 | 0 | 64 |
| 2015 4 | 9 | 0 | 9 |
Mostrar todo
